血管内超声对合并糖耐量减低的冠心病患者临界病变的临床研究

纪军, 何胜虎, 徐日新, 刘晓东, 陈述

纪军, 何胜虎, 徐日新, 刘晓东, 陈述. 血管内超声对合并糖耐量减低的冠心病患者临界病变的临床研究[J]. 实用临床医药杂志, 2012, (17): 11-14.
引用本文: 纪军, 何胜虎, 徐日新, 刘晓东, 陈述. 血管内超声对合并糖耐量减低的冠心病患者临界病变的临床研究[J]. 实用临床医药杂志, 2012, (17): 11-14.
JI Jun, HE Sheng-hu, XU Ri-xin, LIU Xiao-dong, CHEN Shu. Clinical study of intermediate coronary stenosis patients with impaired glucose tolerance by using intravascular ultrasound[J]. Journal of Clinical Medicine in Practice, 2012, (17): 11-14.
Citation: JI Jun, HE Sheng-hu, XU Ri-xin, LIU Xiao-dong, CHEN Shu. Clinical study of intermediate coronary stenosis patients with impaired glucose tolerance by using intravascular ultrasound[J]. Journal of Clinical Medicine in Practice, 2012, (17): 11-14.

血管内超声对合并糖耐量减低的冠心病患者临界病变的临床研究

详细信息
  • 中图分类号: R541.4

Clinical study of intermediate coronary stenosis patients with impaired glucose tolerance by using intravascular ultrasound

  • 摘要: 目的 对于冠脉造影提示临界病变的患者,通过血管内超声检查,了解冠心病合并糖耐量减低的冠脉病变斑块情况,探讨糖耐量减低对冠状动脉病变的影响.方法 89例临床诊断为冠心病的患者,分为合并2型糖尿病(T2DM)组(A组)、糖耐量减低(IGT)组(B组)、糖代谢正常组(NDM)(C组),所有患者均进行冠状动脉造影检查,明确至少有一支主要冠状动脉狭窄程度在40%~70%,所有患者均行血管内超声检查,测量临界病变处血管外弹力膜面积(EEMA)、斑块面积(PA)、最小管腔面积(MLA)、斑块负荷(PB),并分析斑块性质.结果 A组与B组合并高血压及高血脂的发生率较C组高,A组与B组间无显著差别;A组与B组MLA明显<C组,而EEM、PA和PB明显>C组.A组与B组软斑块及血栓形成病例均较C组多见.结论 在冠脉造影提示临界冠脉病变的冠心病患者中,合并糖耐量减低患者与合并糖尿病患者一样,冠脉病变均较严重,且斑块不稳定,故对合并糖耐量减低的冠心病患者应及早干预,积极控制血糖.
  • 李枝萍, 刘军, 徐婷婷. 治疗冠心病并2型糖尿病顽固性空腹高血糖临床体会 [J]. 西南军医, 2011(4):670.doi: 10.3969/j.issn.1672-7193.2011.04.048.
    Braunwald E, Antman E M, Beasley J W. ACC/AHA2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocar dal infarction-summary article:a report of the American College of Cardiology/American Heart Association taskforce on practice guidelines [J]. Journal of the American College of Cardiology, 2002(7):1366.
    Mintz G S, Nissen S E, Anderson W D. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS) [J]. Journal of the American College of Cardiology, 2001(5):1478.
    Takeuchi H, Morino Y, Matsukage T. Impact of vascular remodeling on the coronary plaque compositions:an investigation with in vivo tissue characterization using integrated backscatter-intravascular ultrasound [J]. Atheroclerosis, 2009(2):476.
    Ioannis I, Thomas S, Erminio B. Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents [J]. Journal of the American Medical Association, 2005, (17):2126.
    胡大一, 潘长玉. 中国住院冠心病患者糖代谢异常研究 [J]. 中华内分泌代谢杂志, 2006(1):7.doi: 10.3760/j.issn:1000-6699.2006.01.003.
    Vijan S, Hayward R A. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus:background paper for the American college of physicians [J]. Ann of internal med, 2004.650.
    Raza J A, Movahed A. Current concepts of cardiovascular disease in diabetes mellitus [J]. International Journal of Cardiology, 2003(2):123.
    Pim A L, Bernard De, Nico H.J. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention [J]. New England Journal of Medicine, 2009.213.
计量
  • 文章访问数:  135
  • HTML全文浏览量:  21
  • PDF下载量:  9
  • 被引次数: 0
出版历程
  • 发布日期:  2013-01-15

目录

    /

    返回文章
    返回